Literature DB >> 17078784

Attention-deficit/hyperactivity disorder: using P300 topography to choose optimal treatment.

R Bart Sangal1, JoAnne M Sangal.   

Abstract

Attention-deficit/hyperactivity disorder is the most prevalent behavioral disorder in children, and persists into adulthood. Stimulants (methylphenidate and amphetamines) with dopaminergic mechanisms are the most commonly used pharmacological treatment. Nonselective (desipramine and imipramine) and selective (atomoxetine) norepinephrine reuptake inhibitors can also be effective. What constitutes a sufficient response to treatment? Too often a partial response, leaving the patient symptomatic, is accepted. If response is defined more strictly, allowing for a return to normal, then the usually quoted 70% response rates to any given attention-deficit/hyperactivity disorder medicine drop to approximately 40%. With different medicines and not enough patients responding robustly to any given medicine, we can use medicines sequentially to find the medicine that produces a robust response. Alternatively, P300 topography can be used to select optimal treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17078784     DOI: 10.1586/14737175.6.10.1429

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  3 in total

1.  Predicting the clinical outcome of stimulant medication in pediatric attention-deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a go/no-go test.

Authors:  Geir Ogrim; Juri Kropotov; Jan Ferenc Brunner; Gian Candrian; Leiv Sandvik; Knut A Hestad
Journal:  Neuropsychiatr Dis Treat       Date:  2014-02-03       Impact factor: 2.570

2.  Altered Auditory P300 Performance in Parents with Attention Deficit Hyperactivity Disorder Offspring.

Authors:  Mei Hung Chi; Ching-Lin Chu; I Hui Lee; Yi-Ting Hsieh; Ko Chin Chen; Po See Chen; Yen Kuang Yang
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-11-20       Impact factor: 2.582

3.  A Signature of Attention-Elicited Electrocortical Activity Distinguishes Response From Non-Response to the Non-Stimulant Atomoxetine in Children and Adolescents With ADHD.

Authors:  Kristi R Griffiths; Barbora G Jurigova; John E Leikauf; Donna Palmer; Simon D Clarke; Tracey W Tsang; Erdahl T Teber; Michael R Kohn; Leanne M Williams
Journal:  J Atten Disord       Date:  2017-10-03       Impact factor: 3.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.